These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to news@sciencebusiness.net and sara.crepaldi@sciencebusiness.net. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Hydrogen goes nuclear

The nuclear industry really is interested in playing a role in the hydrogen economy, and meets regularly to review progress.

No fuel like an old fuel cell

Is the UK really neglecting a clean source of energy? Before throwing money into fuel cells, potential investors might like to ask where the energy comes from.

Technology Priorities for the UK

The Department of Trade and Industry has set out a new set of priorities for its investment in R&D. The usual mixed bag, with a nod towards climate change.

Blue biotech emerges from the deep

Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans.

Cytokine for treating autoimmune diseases ready for partnering

PharmaLinks, a business dedicated to commercialising pharmaceutical research, is looking for a development partner for an immunosuppressive cytokine with therapeutic potential in inflammatory diseases including rheumatoid arthritis, asthma, COPD and arteriosclerosis.

After the float: Imperial Innovations

How will Imperial College London's newly floated tech-transfer affiliate invest its stock-market millions? After raising the money, now comes the fun part: spending it.